Both in Pharmaceuticals
Alumis vs Ardelyx
Over the past year ALMS returned +42.5% and ARDX returned −48.8%; their daily moves had a correlation of 0.06.
ALMS +42.5% ARDX −48.8%Growth of $1, one year, split-adjusted
| Metric | ALMS | ARDX |
|---|---|---|
| Price | $6.50 | $3.03 |
| Market cap | $841.3M | $782.3M |
| Today | +1.88% | 0.00% |
| 1 month | −5.0% | −10.6% |
| 6 months | −75.1% | −57.5% |
| Year to date | −33.4% | −48.0% |
| 1 year | +36.8% | −50.0% |
| Revenue growth (YoY) | −37.7% | +23.8% |
| Gross margin | 100.0% | 95.2% |
| Net margin | −8557.2% | −13.8% |
| P/E (TTM) | — | — |
| Price / sales | 113.7× | 1.7× |
| Net cash | $502.3M | $30.0M |
| Dividend yield | — | — |
| Volatility (60d) | 180.4% | 34.2% |
| Short % of float | 11.3% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).